Responses
Poster Presentation
SLE, Sjögren’s and APS - treatment
THU0277 Epratuzumab: Sustained Safety Profile and Effect on Corticosteroid Use on Long-Term Treatment in Patients with Moderate-to-Severe Systemic Lupus Erythematosus: Results from an Open-Label Long-Term Extension Study (Sl0008)
Compose a Response to This Article
Other responses
No responses have been published for this article.